Literature DB >> 23219941

Neural expression of the transcription factor THAP1 during development in rat.

Y Zhao1, J Xiao, S Gong, J A Clara, M S Ledoux.   

Abstract

Loss of function mutations in THAP1 has been associated with primary generalized and focal dystonia in children and adults. THAP1 encodes a transcription factor (THAP1) that harbors an atypical zinc finger domain and plays a critical role in G(1)-S cell cycle control. Current thinking suggests that dystonia may be a neurodevelopmental circuit disorder. Hence, THAP1 may participate in the development of the nervous system. Herein, we report the neurodevelopmental expression patterns of Thap1 transcript and THAP1 protein from the early postnatal period through adulthood in the rat brain, spinal cord and dorsal root ganglia (DRG). We detected Thap1 transcript and THAP1-immunoreactivity (IR) in the cerebral cortex, cerebellum, striatum, substantia nigra, thalamus, spinal cord and DRG. Thap1 transcript expression was higher in the brain than in spinal cord and DRG at P1 and P7 and declined to similar levels at P14 and later time points in all regions except the cerebellum, where it remained high through adulthood. In the brain, THAP1 expression was highest in early development, particularly in the cerebellum at P7. In addition to Purkinje cells in the cerebellum, THAP1-IR was also localized to pyramidal neurons in the cerebral cortex, relay neurons in the thalamus, medium spiny and cholinergic neurons in the striatum, dopaminergic neurons in the substantia nigra, and pyramidal and interneurons in the hippocampus. In the cerebellar cortex, THAP1-IR was prominently distributed in the perikarya and proximal dendrites of Purkinje cells at early time-points. In contrast, it was more diffusely distributed throughout the dendritic arbor of adult Purkinje cells producing a moderate diffuse staining pattern in the molecular layer. At all time points, nuclear IR was weaker than cytoplasmic IR. The prominent cytoplasmic and developmentally regulated expression of THAP1 suggests that THAP1 may function as part of a cell surface-nucleus signaling cascade involved in terminal neural differentiation.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219941      PMCID: PMC3558550          DOI: 10.1016/j.neuroscience.2012.11.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  40 in total

Review 1.  Regulation of terminal differentiation programs in the nervous system.

Authors:  Oliver Hobert
Journal:  Annu Rev Cell Dev Biol       Date:  2011       Impact factor: 13.827

2.  Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.

Authors:  Lucia Cilenti; Meenakshi P Balakrishnan; Xiao-Liang Wang; Camilla Ambivero; Martin Sterlicchi; Federica del Monte; Xin L Ma; Antonis S Zervos
Journal:  J Mol Cell Cardiol       Date:  2010-12-30       Impact factor: 5.000

3.  Dimerization of the DYT6 dystonia protein, THAP1, requires residues within the coiled-coil domain.

Authors:  Cem Sengel; Sophie Gavarini; Nutan Sharma; Laurie J Ozelius; D Cristopher Bragg
Journal:  J Neurochem       Date:  2011-08-08       Impact factor: 5.372

4.  Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration.

Authors:  Daniel Martins-de-Souza; Paul C Guest; David M Mann; Sigrun Roeber; Hassan Rahmoune; Corinna Bauder; Hans Kretzschmar; Benedikt Volk; Atik Baborie; Sabine Bahn
Journal:  J Proteome Res       Date:  2012-03-14       Impact factor: 4.466

5.  Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia.

Authors:  W Sako; R Morigaki; R Kaji; I Tooyama; S Okita; K Kitazato; S Nagahiro; A M Graybiel; S Goto
Journal:  Neuroscience       Date:  2011-05-19       Impact factor: 3.590

Review 6.  DYT6 dystonia: review of the literature and creation of the UMD Locus-Specific Database (LSDB) for mutations in the THAP1 gene.

Authors:  Arnaud Blanchard; Vuthy Ea; Agathe Roubertie; Mélanie Martin; Coline Coquart; Mireille Claustres; Christophe Béroud; Gwenaëlle Collod-Béroud
Journal:  Hum Mutat       Date:  2011-09-15       Impact factor: 4.878

Review 7.  The JAK-STAT pathway at twenty.

Authors:  George R Stark; James E Darnell
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

8.  THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

Authors:  Myriam Roussigne; Corinne Cayrol; Thomas Clouaire; François Amalric; Jean-Philippe Girard
Journal:  Oncogene       Date:  2003-04-24       Impact factor: 9.867

9.  The DYT1 carrier state increases energy demand in the olivocerebellar network.

Authors:  Y Zhao; N Sharma; M S LeDoux
Journal:  Neuroscience       Date:  2011-01-14       Impact factor: 3.590

10.  Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex.

Authors:  Yoshihiro Akimoto; Frank I Comer; Robert N Cole; Akihiko Kudo; Hayato Kawakami; Hiroshi Hirano; Gerald W Hart
Journal:  Brain Res       Date:  2003-03-21       Impact factor: 3.252

View more
  13 in total

Review 1.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

2.  Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia.

Authors:  Vikram G Shakkottai; Amit Batla; Kailash Bhatia; William T Dauer; Christian Dresel; Martin Niethammer; David Eidelberg; Robert S Raike; Yoland Smith; H A Jinnah; Ellen J Hess; Sabine Meunier; Mark Hallett; Rachel Fremont; Kamran Khodakhah; Mark S LeDoux; Traian Popa; Cécile Gallea; Stéphane Lehericy; Andreea C Bostan; Peter L Strick
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 3.  Recent advances in the genetics of dystonia.

Authors:  Jianfeng Xiao; Satya R Vemula; Mark S LeDoux
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

Review 4.  Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

Authors:  Ilhan Akan; Stephanie Olivier-Van Stichelen; Michelle R Bond; John A Hanover
Journal:  J Neurochem       Date:  2017-11-20       Impact factor: 5.372

Review 5.  Emerging common molecular pathways for primary dystonia.

Authors:  Mark S Ledoux; William T Dauer; Thomas T Warner
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

6.  Dystonia type 6 gene product Thap1: identification of a 50 kDa DNA-binding species in neuronal nuclear fractions.

Authors:  Maitane Ortiz-Virumbrales; Marta Ruiz; Eugene Hone; Georgia Dolios; Rong Wang; Andrika Morant; Jessica Kottwitz; Laurie J Ozelius; Sam Gandy; Michelle E Ehrlich
Journal:  Acta Neuropathol Commun       Date:  2014-09-18       Impact factor: 7.801

7.  DYT6 Dystonia: A Neuropathological Study.

Authors:  Reema Paudel; Abi Li; John Hardy; Kailash P Bhatia; Henry Houlden; Janice Holton
Journal:  Neurodegener Dis       Date:  2015-11-27       Impact factor: 2.977

8.  Abnormal cerebellar function and tremor in a mouse model for non-manifesting partially penetrant dystonia type 6.

Authors:  Meike E van der Heijden; Dominic J Kizek; Ross Perez; Elena K Ruff; Michelle E Ehrlich; Roy V Sillitoe
Journal:  J Physiol       Date:  2021-01-09       Impact factor: 5.182

9.  Presynaptic PRRT2 Deficiency Causes Cerebellar Dysfunction and Paroxysmal Kinesigenic Dyskinesia.

Authors:  Dylan J Calame; Jianfeng Xiao; Mohammad Moshahid Khan; T J Hollingsworth; Yi Xue; Abigail L Person; Mark S LeDoux
Journal:  Neuroscience       Date:  2020-09-04       Impact factor: 3.708

10.  A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia.

Authors:  Satya R Vemula; Jianfeng Xiao; Yu Zhao; Robert W Bastian; Joel S Perlmutter; Brad A Racette; Randal C Paniello; Zbigniew K Wszolek; Ryan J Uitti; Jay A Van Gerpen; Peter Hedera; Daniel D Truong; Andrew Blitzer; Monika Rudzińska; Dragana Momčilović; Hyder A Jinnah; Karen Frei; Ronald F Pfeiffer; Mark S LeDoux
Journal:  Mol Genet Genomic Med       Date:  2014-02-11       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.